🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.25
-5.40 (-11.58%)
At close: Nov 20, 2026

Pet Pharm Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
205.4268.65181.79168.4916.76
Short-Term Investments
-250.21206.14--
Cash & Short-Term Investments
205.4518.86387.93168.4916.76
Cash Growth
-60.41%33.75%130.25%905.52%-
Receivables
57.6859.3533.7831.2420.91
Inventory
15.4514.6413.6810.85.81
Prepaid Expenses
-2.062.122.614.79
Other Current Assets
199.415.644.43141.2850.04
Total Current Assets
477.95600.55441.93354.498.31
Property, Plant & Equipment
428.57395.06290.292.4584.57
Goodwill
-8.24---
Other Intangible Assets
88.4285.099.084.055.08
Long-Term Deferred Tax Assets
2.832.832.09--
Other Long-Term Assets
365.68255.2716.7636.673.93
Total Assets
1,3631,347760.06487.58191.89

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
2.53.17.924.812.91
Current Portion of Long-Term Debt
-0.42100--
Current Portion of Leases
11.511.196.426.574.58
Current Income Taxes Payable
-0.02---
Current Unearned Revenue
3.724.814.313.943.09
Other Current Liabilities
44.3836.7221.4116.998.88
Total Current Liabilities
62.156.25140.0532.3119.46
Long-Term Debt
40.9917.34---
Long-Term Leases
69.8177.2237.4641.6337.94
Long-Term Deferred Tax Liabilities
00---
Other Long-Term Liabilities
0.550.55---
Total Liabilities
173.46151.36177.5273.9457.4

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
580.91572.33405.29371.9251.9
Additional Paid-In Capital
577.34574.8878.72150.01-
Retained Earnings
31.7326.8614.51-108.27-117.42
Comprehensive Income & Other
--84.03--
Total Common Equity
1,1901,174582.54413.64134.48
Minority Interest
-21.63---
Shareholders' Equity
1,1901,196582.54413.64134.48
Total Liabilities & Equity
1,3631,347760.06487.58191.89

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
122.3106.16143.8848.242.52
Net Cash (Debt)
83.1412.7244.05120.29-25.77
Net Cash Growth
-79.86%69.11%102.89%--
Net Cash Per Share
1.427.545.903.99-1.02
Filing Date Shares Outstanding
57.9958.0941.6938.2525.18
Total Common Shares Outstanding
57.9958.0941.6938.2525.18
Working Capital
415.85544.3301.88322.178.85
Book Value Per Share
20.5220.2113.9710.815.34
Tangible Book Value
1,1021,081573.47409.59129.4
Tangible Book Value Per Share
19.0018.6013.7610.715.14
Land
-172.41172.41--
Machinery
-147.993.480.4483.92
Construction In Progress
-11.1614.59--
Leasehold Improvements
-73.4851.4739.4735.83